We are live on ! Find out more
QUSVM

Qiming U.S. Ventures Management Portfolio holdings

AUM $55.6M
1-Year Est. Return 98.09%
This Fund
S&P 500
This Quarter Est. Return
+29.53%
1 Year Est. Return
+98.09%
3 Year Est. Return
+1,484.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.4M
AUM Growth
-$1.26M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRML
1
DELISTED
Tourmaline Bio
TRML
$19.1M 37.12%
741,691
– –
JSPR icon
2
Jasper Therapeutics
JSPR
$22.4M
$17.5M 34.02%
928,964
– –
KRRO icon
3
Korro Bio
KRRO
$154M
$12.3M 23.95%
368,085
– –
HLVX
4
DELISTED
HilleVax
HLVX
$984K 1.92%
558,923
– –
VTYX
5
DELISTED
Ventyx Biosciences
VTYX
$899K 1.75%
412,225
– –
KZR
6
DELISTED
Kezar Life Sciences
KZR
$638K 1.24%
82,871
– –

Similar funds

CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
LAM
Lingohr Asset Management Duesseldorf, Germany $57.3M AUM 35.27% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
ITVII
IDG Technology Venture Investment IV Hong Kong $58.3M AUM 89.42% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Qiming U.S. Ventures Management's Q3 2024 Portfolio in Review

As of Q3 2024, Qiming U.S. Ventures Management held 6 positions worth $51.4M, down 2.4% from $52.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Qiming U.S. Ventures Management opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Qiming U.S. Ventures Management's ten largest holdings make up 100% of its $51.4M portfolio in Q3 2024.
  • Qiming U.S. Ventures Management opened 0 new positions and closed 0 in Q3 2024.
  • Qiming U.S. Ventures Management's portfolio value fell 2.4% quarter-over-quarter to $51.4M.

Based on Qiming U.S. Ventures Management's 13F filing for Q3 2024, filed 7 Nov 2024.